Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Medtronic
Boehringer Ingelheim
McKesson
Johnson and Johnson

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for APD791

See Plans and Pricing

« Back to Dashboard

Drug Development Status for APD791: Sponsors, patents, clinical trial progress

APD791 is an investigational drug.

There have been 4 clinical trials for APD791. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2008.

The most common disease conditions in clinical trials are Acute Coronary Syndrome and [disabled in preview]. The leading clinical trial sponsors are Asan Medical Center, Arena Pharmaceuticals, and IlDong Pharmaceutical Co Ltd.

Recent Clinical Trials for APD791
TitleSponsorPhase
Dose-escalation, Repeated and Single Oral Dosing StudyAsan Medical CenterPhase 1
Dose-escalation, Repeated and Single Oral Dosing StudyIlDong Pharmaceutical Co LtdPhase 1
Safety Study of APD-791 With Aspirin and/or ClopidogrelAsan Medical CenterPhase 1

See all APD791 clinical trials

Clinical Trial Summary for APD791

Top disease conditions for APD791
Top clinical trial sponsors for APD791

See all APD791 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Baxter
Harvard Business School
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.